We tend to call a GPCR antibody “validated,” as if the question were settled. The GeneTex team makes the case for a humbler word, characterized, and for handing the hardest reagents in receptor biology back to the researchers who use them.
Spring break at Dr. GPCR — five live Masterclasses scheduled before summer break, examining GPCR science past the equilibrium snapshot. From signaling kinetics to program building, plus two recordings moving into the on-demand library and the community gathering in Boston next week.
Boston, MA and Irvine, CA — [March 18, 2026] — Dr. GPCR, a nonprofit organization serving the global G protein-coupled receptor (GPCR) research community through education, curated scientific content, and community engagement, today announced a strategic media partnership with GeneTex, a multinational antibody manufacturer with long-standing expertise in reagent development and validation. Anti-GPCR antibody specificity has been a persistent challenge in the field — one with